Navigation Links
Biomarkers allow doctors to match therapy to patient
Date:4/13/2008

of the MYCN oncogene, has a particularly poor prognosis and new therapies are urgently needed, said Michelle Haber, Ph.D., professor and executive director of Childrens Cancer Institute Australia for Medical Research in Sydney, Australia. Our findings suggest that MYCN-driven over-expression of ODC1 in this disease, or genetic variations associated with increased expression of the gene, contribute to the aggressive biology of this tumor, and that inhibition of this gene may lead to an important new therapeutic avenue for this disease.

Researchers observed 209 patients with untreated neuroblastoma. As expected, they confirmed that older age, advanced stage and MYCN amplification were all associated with highly aggressive disease and poor clinical outcomes.

In a subsequent animal study, researchers tested whether inhibiting ODC1 activity with difluoromethylornithine (DFMO), a proven ODC1 inhibitor, would improve treatment of neuroblastoma, when used in combination with conventional chemotherapeutic drugs. They found that the combined

DFMO/chemotherapeutic drug therapy prolonged tumor-free survival by comparison with chemotherapeutic drugs alone, suggesting that targeting this oncogene for suppression is a potentially valuable therapeutic approach.

We could actually delay, and in some cases block, neuroblastoma formation in our transgenic MYCN mouse model by continuous exposure to DFMO either from birth or following weaning, and found that this delay was associated with depletion of tumoral polyamines, said Haber.

The next step would be to test DFMO in combination with other chemotherapeutic agents, particularly newer agents that might be most effective in treating drug-resistant disease, and also testing the drug combinations in different models of childhood neuroblastoma. Because DFMO has been shown to be quite safe for use in humans, we would hope that we can proceed rapidly to clinical trials, said Haber.


'/>"/>

Contact: Staci Vernick Goldberg
Staci.goldberg@aacr.org
267-646-0616
American Association for Cancer Research
Source:Eurekalert

Page: 1 2 3 4 5 6 7

Related biology news :

1. Genetic Engineering & Biotechnology News reports on cancer biomarkers
2. A search for biomarkers for early detection of colorectal cancer
3. Colorado Engineering Firms Win NASA Grant to Develop Innovative Insulation for Next Generation Spacecraft - Super-Insulation May Allow Future Energy Efficient Appliances
4. Fine print: New technique allows fast printing of microscopic electronics
5. Rodent fossils allows to determine climate of the Iberian Peninsula 6 million years ago
6. Analysis calls for medical device information to better serve patients and doctors
7. Doctors may be giving the wrong dosage of adrenaline in an emergency because of labelling
8. Doctors learn to control their own brains pain responses to better treat patients
9. Patent Issued for e-Smart Technologies, Inc.s First Biometric Match-on-Card Technology
10. Smartcard Finger-Match Add-on for VeriFinger and MegaMatcher is Now Available for the Implementation of Biometric Fingerprint-on-Smartcard Verification Systems
11. Tassie tiger no match for dingo
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/5/2015)... , Feb. 5, 2015  Marken is starting its ... and has launched a new marketing campaign to solidify ... (CLO).  The new campaign focuses on First ... and shipments. The first headline in the ... Marken,s priorities with its client,s priorities. Marken recognizes the ...
(Date:2/5/2015)... 28, 2015 New Market Research ... Segment Forecasts To 2020 has Been Added to GrandViewReseach.com ... is expected to reach USD 5.10 billion by 2020, ... Inc. IR cameras help identify the site of tissue ... witness surging demand in medical imaging applications. They have ...
(Date:2/5/2015)... , Feb. 3, 2015 Despite ... demand from industries such as consumer electronics, automotive, ... for surface mount technology (SMT) screen printers. Innovations ... automatic control will push the adoption curve up. ... remain steady as glue dispensers are indispensable in ...
Breaking Biology News(10 mins):Marken Launches New Patient-Centric Campaign 2IR Camera Market Worth $5.10 Billion By 2020: Grand View Research, Inc. 2IR Camera Market Worth $5.10 Billion By 2020: Grand View Research, Inc. 3End-user Demand Spurs Global SMT Screen Printers and Glue Dispensers Market 2End-user Demand Spurs Global SMT Screen Printers and Glue Dispensers Market 3
... 75% of all animal species in the world are ... species). Beetles can be very beautiful and colorful, but ... can destroy food plants like potatoes (the Colorado potato ... pests cause U.S. $ 26 billion in losses to ...
... Mass., March 25, 2008 -- Scientists at Harvard ... freshwater invertebrate animals called bdelloid rotifers are extraordinarily ... reproduce after doses of gamma radiation much greater ... studied to date. Because free radicals such ...
... of Bioscience Horizons, a unique peer-reviewed journal comprising entirely ... UK and Republic of Ireland. Bioscience Horizons ... between the universities of Leeds, Nottingham, Reading, Chester and ... a forum for the brightest undergraduates in the UK ...
Cached Biology News:Common aquatic animals show extreme resistance to radiation 2
(Date:2/27/2015)... 27, 2015 Immunovaccine Inc. (“Immunovaccine”) ... company, today announced that the U.S. Food and ... Track designation and Phase I clinical trials of ... the mutual co-development agreement signed with Gilead Life ... designation for the DPX-Survivac. , “We have been ...
(Date:2/27/2015)... FamilyFarms Group is pleased to announce its ... Farms, received the 2015 Tomorrow’s Top Producer Horizon Award. ... of 35, who has demonstrated excellence in the business ... the Tomorrow's Top Producer Horizon Award. Every year I ... Award and learning from their experiences. It is truly ...
(Date:2/26/2015)... Feb. 26, 2015 S&P Capital IQ (MHFI) ... Report coverage on MabVax Therapeutics Holdings Inc . ... clinical stage biotechnology company focused on the development of ... in the treatment of cancer. MabVax has discovered a ... protective immune responses generated by patients who have been ...
(Date:2/26/2015)... 2015   Synageva BioPharma Corp. (NASDAQ: ... therapeutic products for rare disorders, today reported 2014 ... other key objectives, and financial guidance.  Synageva,s management ... 4:30 p.m. EST to review the financial results ... in today,s call by telephone, please dial (877) ...
Breaking Biology Technology:Immunovaccine Inc. (TSX: IMV) receives Fast Track and Phase I trial approval for Ebola and Anthrax vaccine programs, signs co-development agreement with Gilead Sciences 2Immunovaccine Inc. (TSX: IMV) receives Fast Track and Phase I trial approval for Ebola and Anthrax vaccine programs, signs co-development agreement with Gilead Sciences 3Matt Sims Receives the 2015 Tomorrow’s Top Producer Horizon Award 2S&P Capital IQ Initiates Coverage on MabVax Therapeutics Holdings Inc. in S&P Capital IQ Factual Stock Reports 2S&P Capital IQ Initiates Coverage on MabVax Therapeutics Holdings Inc. in S&P Capital IQ Factual Stock Reports 3S&P Capital IQ Initiates Coverage on MabVax Therapeutics Holdings Inc. in S&P Capital IQ Factual Stock Reports 4S&P Capital IQ Initiates Coverage on MabVax Therapeutics Holdings Inc. in S&P Capital IQ Factual Stock Reports 5Synageva BioPharma Reports 2014 Full Year Financial Results 2Synageva BioPharma Reports 2014 Full Year Financial Results 3Synageva BioPharma Reports 2014 Full Year Financial Results 4Synageva BioPharma Reports 2014 Full Year Financial Results 5Synageva BioPharma Reports 2014 Full Year Financial Results 6Synageva BioPharma Reports 2014 Full Year Financial Results 7Synageva BioPharma Reports 2014 Full Year Financial Results 8Synageva BioPharma Reports 2014 Full Year Financial Results 9
... SAN DIEGO, Aug. 25 Amylin Pharmaceuticals,Inc. (Nasdaq: ... LLY ) will Web cast a,conference call on ... to,discuss the recent FDA advisory on BYETTA(R) (exenatide) injection. ... Amylin,s President and,Chief Executive Officer and Orville G. Kolterman, ...
... Chief ... SUNNYVALE, Calif., Aug. 25 Avantis Medical Systems,Inc. announced ... as President and Chief Executive Officer (CEO), and Larry,Tannenbaum as ... assume key roles with the Avantis management team., "We ...
... China, Aug. 25 /Xinhua-PRNewswire-FirstCall/ -- 3SBio Inc.,(Nasdaq: ... researching,developing, manufacturing and marketing biopharmaceutical products,primarily in China, ... at the Morgan Stanley Global Healthcare Unplugged Conference ... 8:35 AM., A copy of the latest ...
Cached Biology Technology:Amylin and Lilly Set Date and Time for Conference Call 2Avantis Medical Systems, Inc. Announces Key Leadership Appointments 2
Anti-Protein Kinase-A (PKA) Regulatory subunit IIB; rabbit host...
Identify and characterize Phosphoinositide (PI(3,4,5)P3) binding...
Mouse monoclonal antibody to RNase L...
Compact, portable device, seals 96 and 384 well plates with preset temperature optimised for Eppendorf heat sealing foils and films. Suitable for plates of different heights. AC input: 50/60 Hz230 V...
Biology Products: